New Site for Bosch Packaging Technology
Bosch Packaging Technology has moved into a new location at Musashi, some 70 km north of Tokyo. Since the move there in late March, more than 100 associates have been developing and manufacturing inspection technology for the pharmaceuticals industry on premises covering 3,240 m2.
A total of some 1.6 million euros was invested in the new site. Following relocation from Honjo to the much larger Musashi site, Bosch Packaging Technology now has considerably more space at its disposal for the development and assembly of its machines. This investment in the Musashi site underscores the company's commitment to Japan as a major market for pharmaceuticals inspection technology.
“Expansion of the Bosch global center of competence in Japan is important for our innovative strength,” said Peter Tyroller, the member of the Bosch board of management with responsibility for the Asia-Pacific region. “We want to offer our customers outstanding products that are both beneficial and fascinating.”
Inspection Technology by Bosch Packaging Technology
In the pharmaceuticals industry, demand for product safety and quality — and thus also for inspection solutions — is constantly rising. “We want to build on the experience we have amassed in Japan over many decades and offer our customers technology that is 'Invented for life' around the world,” said Joachim Baczewski, head of the Inspection Technology Pharma unit and general manager of Bosch Packaging Technology in Japan.
The Inspection Technology unit was established in 2012 following the acquisition of Eisai Machinery, a Japanese company. It comprises manual, semi-automated, and fully automated inspection machines designed to identify particles in pharmaceutical products. It also includes the cosmetic inspection of containers or tablets to detect defects such as scratches or discoloration.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance